Stomatin inhibitors comprise a diverse set of chemicals that have the potential to modulate the activity of Stomatin, a protein involved in various cellular processes, including ion channel regulation and membrane integrity. While direct inhibitors specific to Stomatin may not be well-defined, several chemicals can indirectly influence Stomatin by targeting ion channels, receptors, or signaling pathways associated with its function. Benzamil, a selective inhibitor of the epithelial sodium channel (ENaC), indirectly influences Stomatin by modulating ion channel activity and intracellular sodium concentrations. This alteration in ion homeostasis can impact Stomatin-mediated cellular responses. E-4031, a selective inhibitor of the rapid delayed rectifier potassium current (IKr), may indirectly affect Stomatin by modulating potassium channel activity and membrane potential, potentially influencing Stomatin function. Nifedipine, a calcium channel blocker, indirectly influences Stomatin by modulating calcium channel activity, affecting intracellular calcium concentrations and cellular processes where Stomatin is involved. Chlorpromazine, a dopamine receptor antagonist, indirectly influences Stomatin by modulating dopamine receptor signaling pathways, potentially affecting Stomatin expression or function in responsive cells.
Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), indirectly impacts Stomatin by modulating inflammatory pathways, potentially affecting Stomatin expression or function in cells responsive to inflammatory signals. BAPTA-AM, a cell-permeable calcium chelator, indirectly influences Stomatin by chelating intracellular calcium, potentially affecting cellular processes sensitive to changes in calcium concentrations. Resveratrol, a polyphenolic compound, indirectly influences Stomatin by modulating various signaling pathways, potentially affecting Stomatin expression or function in responsive cells. SKF-96365, a non-selective inhibitor of receptor-operated calcium channels, indirectly impacts Stomatin by inhibiting calcium channel activity, potentially influencing cellular processes sensitive to changes in calcium concentrations. This diverse array of chemicals highlights the intricate interplay between Stomatin and various cellular components, offering valuable tools for researchers studying Stomatin-related pathways and functions. The indirect mechanisms of action underscore the complexity of Stomatin regulation and its integration into multiple cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Tamoxifen is a selective estrogen receptor modulator. While not directly targeting Stomatin, Tamoxifen may indirectly influence Stomatin by modulating estrogen receptor signaling pathways, potentially affecting Stomatin expression or function in estrogen-responsive cells. | ||||||
Glyburide (Glibenclamide) | 10238-21-8 | sc-200982 sc-200982A sc-200982D sc-200982B sc-200982C | 1 g 5 g 25 g 100 g 500 g | $46.00 $61.00 $117.00 $173.00 $530.00 | 36 | |
Glibenclamide is an ATP-sensitive potassium channel (KATP) blocker. Indirectly, it may impact Stomatin by affecting KATP channel activity, influencing membrane potential and ion homeostasis, and potentially modulating Stomatin function in cells expressing KATP channels. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Amiloride is an inhibitor of sodium channels. Indirectly, it may impact Stomatin by modulating sodium channel activity and intracellular sodium concentrations, potentially influencing Stomatin-mediated cellular responses. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine is a calcium channel blocker. While not directly targeting Stomatin, Nifedipine may indirectly influence Stomatin by modulating calcium channel activity, potentially affecting intracellular calcium concentrations and cellular processes where Stomatin is involved. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine is a dopamine receptor antagonist. While not directly targeting Stomatin, Chlorpromazine may indirectly influence Stomatin by modulating dopamine receptor signaling pathways, potentially affecting Stomatin expression or function in cells responsive to dopamine signaling. | ||||||
Diclofenac acid | 15307-86-5 | sc-357332 sc-357332A | 5 g 25 g | $109.00 $298.00 | 5 | |
Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID). While not directly targeting Stomatin, Diclofenac may indirectly influence Stomatin by modulating inflammatory pathways, potentially affecting Stomatin expression or function in cells responsive to inflammatory signals. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM is a cell-permeable calcium chelator. Indirectly, it may impact Stomatin by chelating intracellular calcium, potentially influencing cellular processes where Stomatin is sensitive to changes in calcium concentrations. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $103.00 $158.00 $397.00 $656.00 | 2 | |
SKF-96365 is a non-selective inhibitor of receptor-operated calcium channels. Indirectly, it may impact Stomatin by inhibiting calcium channel activity, potentially influencing cellular processes where Stomatin is sensitive to changes in calcium concentrations. | ||||||